S Ingen-Housz-Oro1, N Ortonne, O Chosidow. Show Affiliations » 1. Department of Dermatology, AP-HP, Henri Mondor Hospital, Créteil, France.
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAntibodies, Monoclonal, Murine-Derived/administration & dosageAntibodies, Monoclonal, Murine-Derived/adverse effectsAntibodies, Monoclonal, Murine-Derived/therapeutic useAntineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useChlorpheniramine/pharmacologyChlorpheniramine/therapeutic useHistamine H1 Antagonists/pharmacologyHistamine H1 Antagonists/therapeutic useHumansInfusions, IntravenousLymphoma, Follicular/drug therapyLymphoma, Follicular/pathologyMaleMast Cells/drug effectsMast Cells/pathologyRituximabSkin/drug effectsSkin/pathologySkin Neoplasms/drug therapySkin Neoplasms/pathologyTreatment OutcomeUrticaria/chemically inducedUrticaria/diagnosisUrticaria/drug therapy
Substances： See more » Antibodies, Monoclonal, Murine-DerivedAntineoplastic AgentsHistamine H1 AntagonistsdexchlorpheniramineChlorpheniramineRituximab
Year: 2013 PMID： 24206369 DOI： 10.1111/jdv.12313
Source DB: PubMed Journal: J Eur Acad Dermatol Venereol ISSN： 0926-9959 Impact factor: 6.166